Displaying drugs 826 - 850 of 1287 in total
BBP-711
BBP-711 is a glycolate oxidase inhibitor.
Investigational
Matched Description: … BBP-711 is a glycolate oxidase inhibitor. …
LY-294002
Specific inhibitor of phosphatidylinositol 3-kinase.
Experimental
Matched Description: … Specific inhibitor of phosphatidylinositol 3-kinase. …
SGX-523
A MET receptor tyrosine kinase inhibitor.
Investigational
Matched Description: … A MET receptor tyrosine kinase inhibitor. …
Cenisertib
Cenisertib is an aurora kinase inhibitor.
Investigational
Matched Description: … Cenisertib is an aurora kinase inhibitor. …
Acifluorfen
Acifluorfen is a protoporphyrinogen oxidase inhibitor.
Experimental
Matched Description: … Acifluorfen is a protoporphyrinogen oxidase inhibitor. …
DSP-5336
DSP-5336 is a menin inhibitor.
Investigational
Matched Description: … DSP-5336 is a menin inhibitor. …
Ubenimex
Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
Investigational
Matched Description: … Ubenimex (also known as bestatin) is a competitive protease inhibitor. ... It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. …
Filaminast
Filaminast is a phosphodiesterase 4 inhibitor (PDE4 inhibitor). As such, has potential in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Experimental
Matched Description: … Filaminast is a phosphodiesterase 4 inhibitor (PDE4 inhibitor). …
Vinylglycine
Vinylglycine is an irreversible inhibitor of aspartate aminotransferase.
Experimental
Matched Description: … Vinylglycine is an irreversible inhibitor of aspartate aminotransferase. …
AB192
AB192 is a DPP IV enzymatic activity inhibitor.
Experimental
Matched Description: … AB192 is a DPP IV enzymatic activity inhibitor. …
Indatraline
Indatraline is a nonselective monoamine reuptake inhibitor.
Investigational
Matched Description: … Indatraline is a nonselective monoamine reuptake inhibitor.[A253022] …
(S)-Rolipram
A phosphodiesterase inhibitor with antidepressant properties. [PubChem]
Experimental
Matched Description: … A phosphodiesterase inhibitor with antidepressant properties. [PubChem] …
CPI-1205
Potent and selective histone methyltransferase EZH2 inhibitor.
Investigational
Matched Description: … Potent and selective histone methyltransferase EZH2 inhibitor. …
Diphenyleneiodonium
An NADPH oxidase 2 (NOX2) inhibitor.
Investigational
Matched Description: … An NADPH oxidase 2 (NOX2) inhibitor.[A252987] …
Banoxantrone
Banoxantrone is a highly selective bioreductive drug that is activated in, and is preferentially toxic to, hypoxic cells in tumours. It has been shown to work synergistically with fractionated radiation to significantly delay growth of tumours compared to administration of either banoxantrone or radiation alone. Banoxantrone was also efficacious in...
Investigational
Zatolmilast
BPN-14770 is under investigation in clinical trial NCT02840279 (A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects).
Investigational
Matched Categories: … Small Molecule Allosteric Inhibitor of the Phosphodiesterase-4D Enzyme …
SB-218078
SB-218078 is a specific inhibitor of CHK1.
Investigational
Matched Description: … SB-218078 is a specific inhibitor of CHK1.[A253117] …
S-Ethylisothiourea
S-Ethylisothiourea is a nitric oxide synthase inhibitor.
Experimental
Matched Description: … S-Ethylisothiourea is a nitric oxide synthase inhibitor. …
Ilomastat
Ilomastat is a broad-spectrum matrix metalloproteinase inhibitor.
Experimental
Matched Description: … Ilomastat is a broad-spectrum matrix metalloproteinase inhibitor. …
Abacavir hydroxyacetate
Prurisol is under investigation for the treatment of Chronic Stable Plaque Psoriasis. Prurisol has been investigated for the treatment of Plaque Psoriasis.
Investigational
Matched Categories: … Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor …
Vafidemstat
Vafidemstat is under investigation in clinical trial NCT03867253 (Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease).
Investigational
Remikiren
Remikiren is an orally active, high specificity renin inhibitor.
Experimental
Matched Description: … Remikiren is an orally active, high specificity renin inhibitor. …
Estrane-3,17-dione
Estrane-3,17-dione is a potent inhibitor of isomerase.
Experimental
Matched Description: … Estrane-3,17-dione is a potent inhibitor of isomerase. …
PD-168393
PD-168393 is an epidermal growth factor receptor inhibitor.
Experimental
Matched Description: … PD-168393 is an epidermal growth factor receptor inhibitor. …
MK-886
MK-886 is an experimental inhibitor of leukotriene synthesis.
Experimental
Matched Description: … MK-886 is an experimental inhibitor of leukotriene synthesis. …
Displaying drugs 826 - 850 of 1287 in total